Skip to main content
logo
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China flag China · Delayed Price · Currency is CNY
41.94
-2.58 (-5.80%)
Mar 4, 2026, 2:15 PM CST

SHE:300255 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Market Capitalization
40,91718,37211,9575,0367,4725,693
Market Cap Growth
143.01%53.65%137.41%-32.59%31.26%11.92%
Enterprise Value
43,21720,35214,0916,8178,6176,631
Last Close Price
44.5219.9913.015.478.096.15
PE Ratio
---287.5831.9922.52
Forward PE
-12.4412.4412.4412.4412.44
PS Ratio
44.0917.828.482.162.522.41
PB Ratio
27.6711.966.641.652.432.00
P/TBV Ratio
33.7314.658.021.802.682.20
P/OCF Ratio
848.50326.80354.531611.412602.11-
EV/Sales Ratio
46.5719.749.992.922.902.81
EV/EBITDA Ratio
---41.3322.6815.64
EV/EBIT Ratio
---63.1326.5917.98
EV/FCF Ratio
-297.03-----
Debt / Equity Ratio
1.751.661.320.820.570.47
Debt / EBITDA Ratio
---15.104.583.14
Net Debt / Equity Ratio
1.581.501.190.550.390.30
Net Debt / EBITDA Ratio
-19.16-21.58-1.9910.263.152.01
Net Debt / FCF Ratio
-16.08-12.57-10.39-3.95-3.92-2.22
Asset Turnover
0.200.230.270.420.610.56
Inventory Turnover
0.620.620.850.560.600.45
Quick Ratio
0.240.250.290.720.520.67
Current Ratio
0.870.911.192.181.972.12
Return on Equity (ROE)
-18.04%-15.83%-51.43%0.33%7.81%9.01%
Return on Assets (ROA)
-2.57%-2.45%-13.46%1.20%4.15%5.41%
Return on Invested Capital (ROIC)
-5.08%-4.60%-26.38%1.34%7.22%9.15%
Return on Capital Employed (ROCE)
-8.50%-7.70%-42.80%2.50%9.40%11.70%
Earnings Yield
-0.74%-1.36%-10.37%0.35%3.13%4.44%
FCF Yield
-0.36%-1.00%-1.72%-8.50%-4.08%-6.73%
Dividend Yield
---0.09%0.32%-
Payout Ratio
---708.02%26.50%27.08%
Buyback Yield / Dilution
-35.95%-0.58%-4.91%6.27%0.23%0.24%
Total Shareholder Return
-35.95%-0.58%-4.91%6.37%0.55%0.24%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.